SCHEMBL31687285

SCHEMBL31687285

Cc1nc(N[C@H]2CCNC2)ccc1-c1ncc(Cl)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 7/20 0.45
▸ NRAS P01111 5/20 0.45
▸ IRAK4 Q9NWZ3 4/20 0.45
▸ IRAK1 P51617 2/20 0.45
▸ MAP4K1 Q92918 1/20 0.40
▸ HRH3 Q9Y5N1 3/20 0.40
▸ HRH4 Q9H3N8 2/20 0.40
▸ HRH2 P25021 1/20 0.40
▸ LCK P06239 1/20 0.39
▸ RET P07949 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ CDK7 P50613 1/20 0.39
▸ BLK P51451 1/20 0.39
▸ CCNH P51946 1/20 0.39
▸ SRPK1 Q96SB4 1/20 0.39
▸ PRKCI P41743 2/20 0.39
▸ BPTF Q12830 2/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31687286 0.86 CYP1A2 (0.47) FLT3NRASIRAK4IRAK1MAP4K1
SCHEMBL30833322 0.86 CYP1A2 (0.47) FLT3NRASIRAK4IRAK1MAP4K1
SCHEMBL31687271 0.86 PRKCI (0.42) FLT3NRASIRAK4IRAK1MAP4K1
Hydrochloric Acid SCHEMBL30457682 0.85 CYP1A2 (0.46) FLT3NRASIRAK4IRAK1MAP4K1
SCHEMBL31687296 0.84 CYP1A2 (0.46) FLT3NRASIRAK4IRAK1MAP4K1
SCHEMBL31687300 0.77 CYP1A2 (0.43) FLT3NRASMAP4K1HRH3HRH4
SCHEMBL31634664 0.77 CYP1A2 (0.43) FLT3NRASMAP4K1HRH3HRH4
SCHEMBL22895705 0.76 FLT3 (0.51) FLT3NRASIRAK4IRAK1LCK
Hydrochloric Acid SCHEMBL30996519 0.76 MC4R (0.39) FLT3NRASIRAK4IRAK1HRH3
Hydrochloric Acid SCHEMBL28544420 0.75 FLT3 (0.50) FLT3NRASIRAK4IRAK1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4620955-A1 MC4R ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL USE THEREOF Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2025-09-24 — — EP disclosed
Send feedback